Gilead Sciences GILD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $7.56B-24.3% | $9.99B+64.2% | $6.09B+12.4% | $5.41B+1.4% | ||
| $68M— | $0-100% | $1.18B+21.2% | $973M-17.7% | ||
| $5.9B+10.8% | $5.32B-3.2% | $5.5B+0.6% | $5.46B+3.5% | ||
| $2.59B+38.1% | $1.88B+19.1% | $1.58B+20.2% | $1.31B+17.7% | ||
| $1.41B+9.2% | $1.3B+3.9% | $1.25B+5.9% | $1.18B+5.8% | ||
| $1.31B+54.2% | $847M0.0% | $847M+46.8% | $577M-2.2% | ||
| $4.02B+31.8% | $3.05B+28.6% | $2.37B+33.8% | $1.77B-17.1% | ||
| $18.34B-4.3% | $19.17B+19.2% | $16.09B+11.4% | $14.44B-2.2% | ||
| $5.61B+3.5% | $5.41B+1.8% | $5.32B-2.9% | $5.48B+6.9% | ||
| $2.7B+9.1% | $2.47B-80.1% | $12.44B+22.9% | $10.12B+20.8% | ||
| $8.31B0.0% | $8.31B0.0% | $8.31B0.0% | $8.31B-0.2% | ||
| $2.36B-29.7% | $3.36B-58.4% | $8.08B-36.7% | $12.76B-28.3% | ||
| $59.02B0.0% | $59B-5.0% | $62.13B-1.7% | $63.17B-7.0% | ||
| $715M-14.2% | $833M+51.5% | $550M-39.2% | $905M+28.4% | ||
| $2.81B+54.7% | $1.82B+0.9% | $1.8B-20.9% | $2.27B+49.9% | ||
| $11.81B-1.6% | $12B+6.4% | $11.28B+0.4% | $11.24B-3.2% | ||
| $22.13B-11.1% | $24.9B+7.4% | $23.19B+1.0% | $22.96B-8.8% | ||
| $1.17B-10.0% | $1.3B+1.2% | $1.28B+8.6% | $1.18B+20.8% | ||
| $8.93B+16.0% | $7.7B+18.5% | $6.5B+17.1% | $5.55B+19.1% | ||
| $13.73B+19.4% | $11.5B-29.5% | $16.3B+3.9% | $15.69B-3.9% | ||
| $39M-70.5% | $132M+371% | $28M+1,300% | $2M-97.6% | ||
| $22.7B+17.4% | $19.33B-15.3% | $22.83B+7.5% | $21.24B+0.8% | ||
| $59.02B0.0% | $59B-5.0% | $62.13B-1.7% | $63.17B-7.0% | ||
| —— | —— | —— | —— | ||
| $724M— | —— | $727M-39.6% | $1.2B— | ||
| $724M— | —— | $727M-39.6% | $1.2B— | ||
| $1.65B+13.8% | $1.45B+13.8% | $1.27B+19.3% | $1.07B+3.3% | ||
| $68M— | $0-100% | $1.18B+21.2% | $973M-17.7% | ||
| $56M-56.3% | $128M+1,729% | $7M-88.3% | $60M-25.0% | ||
| $4.85B+28.5% | $3.77B-21.3% | $4.79B-0.2% | $4.8B-3.3% | ||
| $8.91B-17.4% | $10.79B+64.8% | $6.55B— | —— | ||
| $2.3B-20.4% | $2.89B-59.1% | $7.07B— | —— | ||
| $2.3B-20.4% | $2.89B-59.1% | $7.07B— | —— | ||
| $2.3B-20.4% | $2.89B-59.1% | $7.07B— | —— | ||
| $2.3B-20.4% | $2.89B-59.1% | $7.07B— | —— | ||
| $1.96B-17.4% | $2.38B— | —— | —— | ||
| $14.68B-14.0% | $17.06B-12.0% | $19.38B+23.7% | $15.67B-10.6% | ||
| $16.98B-14.9% | $19.95B-24.6% | $26.45B-8.4% | $28.89B-13.6% | ||
| $2.97B— | $0-100% | $1.16B-6.6% | $1.25B-4.9% | ||
| $4.85B+28.5% | $3.77B-21.3% | $4.79B-0.2% | $4.8B-3.3% | ||
| $8.3B+5.3% | $7.88B— | —— | —— | ||
| $4.85B+28.5% | $3.77B-21.3% | $4.79B-0.2% | $4.8B-3.3% | ||
| $4.34B+11.4% | $3.89B+2.4% | $3.8B+9.3% | $3.48B+7.2% | ||
| $3.95B-27.7% | $5.46B+6.5% | $5.13B+12.0% | $4.58B-25.5% | ||
| $40M+1,233% | $3M-57.1% | $7M-80.6% | $36M+800% | ||
| $97M+9.0% | $89M-11.9% | $101M+21.7% | $83M+23.9% | ||
| $0— | $0— | $0-100% | $1M0.0% | ||
| $1M0.0% | $1M0.0% | $1M0.0% | $1M0.0% | ||
| $0— | $0— | $0— | $0— | ||
| $3.9B+34.5% | $2.9B+16.0% | $2.5B-16.7% | $3B+3.4% | ||
| $8.3B+5.3% | $7.88B— | —— | —— | ||
| $843M+11.1% | $759M+11.8% | $679M+23.7% | $549M-18.2% | ||
| $896M+8.0% | $830M-59.3% | $2.04B-47.9% | $3.92B-17.9% | ||
| $41M-21.2% | $52M-7.1% | $56M+1.8% | $55M+17.0% | ||
| $1M— | —— | $10M-70.6% | $34M+750% | ||
| $11M— | —— | $5M+400% | $1M— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 5.6B0.0% | 5.6B0.0% | 5.6B0.0% | 5.6B0.0% | ||
| 1.2B-0.4% | 1.2B0.0% | 1.2B-0.1% | 1.2B-0.6% | ||
| 1.2B-0.4% | 1.2B0.0% | 1.2B-0.1% | 1.2B-0.6% | ||
| $629M+127% | $277M+137% | $117M-31.6% | $171M-1.7% | ||
| $48M-17.2% | $58M-46.8% | $109M+6.9% | $102M+29.1% | ||
| $2.81B+54.7% | $1.82B+0.9% | $1.8B-20.9% | $2.27B+49.9% | ||
| $3.03B— | $0-100% | $2.43B+4.5% | $2.33B-7.0% | ||
| $724M— | —— | $727M-39.6% | $1.2B— | ||
| $3.04B— | —— | $2.43B+5.8% | $2.29B-8.2% | ||
| $402M-44.5% | $724M-54.4% | $1.59B-40.6% | $2.67B-38.6% | ||
| $16M-87.2% | $125M— | —— | —— | ||
| $40M— | —— | —— | —— | ||
| $32M— | $0— | —— | —— | ||
| $40M+1,233% | $3M-57.1% | $7M-80.6% | $36M+800% | ||
| $3.9B+34.5% | $2.9B+16.0% | $2.5B-16.7% | $3B+3.4% | ||
| $17.21B+16.1% | $14.82B+19.2% | $12.44B+22.9% | $10.12B+20.8% | ||
| $31.89B0.0% | $31.88B+0.2% | $31.82B+23.4% | $25.79B-0.5% | ||
| $2.3B-20.4% | $2.89B-59.1% | $7.07B— | —— | ||
| $34.19B-1.7% | $34.77B-10.6% | $38.89B-0.3% | $39.01B-6.7% | ||
| $4.37B+21.7% | $3.59B+6.6% | $3.37B+19.4% | $2.82B+3.1% | ||
| $0-100% | $242M— | —— | —— | ||
| -$84M0.0% | -$84M0.0% | -$84M-171% | -$31M-520% | ||
| $393M+1.8% | $386M+13.5% | $340M— | —— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 5M0.0% | 5M0.0% | 5M0.0% | 5M0.0% | ||
| 0— | 0— | 0— | 0— | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Gilead Sciences's total assets?
- Gilead Sciences (GILD) holds $56.3B in total assets, down 0.3% year over year.
- How much debt does Gilead Sciences have?
- Gilead Sciences carries $22.2B in total debt against $23.5B of shareholders' equity, a debt-to-equity ratio of 0.94.
- How much cash does Gilead Sciences have?
- Gilead Sciences holds $7.6B in cash and equivalents.
- Can Gilead Sciences cover its short-term obligations?
- Its current ratio is 1.97 — current assets exceed current liabilities.
- Where does Gilead Sciences's balance sheet data come from?
- Every line is extracted from Gilead Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
